Organon & Co.·4

Mar 31, 4:08 PM ET

Falcione Aaron 4

4 · Organon & Co. · Filed Mar 31, 2026

Research Summary

AI-generated summary of this filing

Updated

Organon (OGN) CHRO Aaron Falcione Receives RSUs; Withholds 2,885 Shares

What Happened

  • Aaron Falcione, Chief Human Resources Officer of Organon & Co. (OGN), had 8,422 restricted stock units (RSUs vest) converted into common shares on March 29, 2026. As part of the vesting event, 2,885 shares were withheld to cover tax liabilities at a withholding price of $5.84 per share, totaling $16,848. The filing records the conversion/exercise of the derivative (RSU) and the tax-withholding disposition.

Key Details

  • Transaction date: March 29, 2026 (reported on Form 4 filed March 31, 2026).
  • Vesting/conversion: 8,422 RSUs converted to 8,422 shares (derivative exercise/conversion, code M).
  • Tax withholding: 2,885 shares withheld/disposed to cover taxes at $5.84/share, total $16,848 (code F). $5.84 is the closing market price on March 27, 2026 per the plan.
  • Each RSU equals one share (footnote); these RSUs vest in three equal installments on Mar 29 of 2025, 2026, and 2027.
  • Shares owned after the transaction: not specified in this filing.
  • Filing timeliness: Report filed two days after the transaction date; appears timely under standard reporting rules.

Context

  • This was a standard RSU vesting and tax-withholding event, not a market purchase or deliberate sale for investment purposes. The conversion of RSUs to shares (derivative exercise) with shares withheld for taxes is routine compensation administration rather than a directional insider trade.

Insider Transaction Report

Form 4
Period: 2026-03-29
Falcione Aaron
Chief Human Resources Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-03-29+8,42292,531.071 total
  • Tax Payment

    Common Stock

    [F1]
    2026-03-29$5.84/sh2,885$16,84889,646.071 total
  • Exercise/Conversion

    Restricted Stock Units

    [F2][F3]
    2026-03-298,4228,422 total
    Common Stock (8,422 underlying)
Footnotes (3)
  • [F1]This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 27, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.
  • [F2]Each RSU represents a contingent right to receive one share of Organon common stock.
  • [F3]These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Aaron Falcione|2026-03-31

Documents

1 file
  • 4
    wk-form4_1774987683.xmlPrimary

    FORM 4